Capricorn Fund Managers LTD has filed its 13F form on October 17, 2025 for Q3 2025 where it was disclosed a total value porftolio of $262 Million distributed in 59 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Tarsus Pharmaceuticals, Inc. with a value of $14.3M, Microsoft Corp with a value of $14.1M, Vera Therapeutics, Inc. with a value of $13.1M, The Real Real, Inc. with a value of $12.8M, and Alphabet Inc. with a value of $11.5M.

Examining the 13F form we can see an increase of $78.6M in the current position value, from $183M to 262M.

Capricorn Fund Managers LTD is based out at London, X0

Below you can find more details about Capricorn Fund Managers LTD portfolio as well as his latest detailed transactions.

Portfolio value $262 Million
Healthcare: $102 Million
Consumer Cyclical: $59 Million
Communication Services: $26.9 Million
Technology: $25.2 Million
Financial Services: $21.2 Million
Consumer Defensive: $11.4 Million
Energy: $6.94 Million
Industrials: $5.38 Million
Other: $3.81 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 59
  • Current Value $262 Million
  • Prior Value $183 Million
  • Filing
  • Period Q3 2025
  • Filing Date October 17, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 24 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 22 stocks
Track This Portfolio

Track Capricorn Fund Managers LTD Portfolio

Follow Capricorn Fund Managers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capricorn Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capricorn Fund Managers LTD with notifications on news.